Research Article
Real-Life Use of Tocilizumab in the Treatment of Severe COVID-19 Pneumonia
Table 3
Change in clinical status in patients with TCZ.
| Clinical status | Baseline TCZ (%) | Day 14(%) | Day 28(%) |
| 1. Discharged from hospital | 0 | 52.8 | 80 | 2. Hospitalization, not requiring supplemental O2 | 2.4 | 9.6 | 3.2 | 3. Hospitalization, requiring supplemental low-flow O2 | 38.4 | 13.6 | 1.6 | 4. Hospitalization, requiring NIV and/or high-flow supplemental O2 | 55.2 | 12.8 | 2.4 | 5. Hospitalization, requiring invasive mechanical ventilation or ECMO | 4 | 9.6 | 7.2 | 6. Death | 0 | 1.6 | 5.6 |
|
|